openPR Logo
Press release

Leadless Pacing Systems Market: Segment Snapshot and Table of Content (2017-2025)

12-19-2017 01:50 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Leadless Pacing Systems Market: Segment Snapshot and Table

Leadless pacing system is a novel technology in the cardiac pacemakers market. These are smaller in size than conventional pacemakers along with the absence of leads thus eliminating potential lead and pacemaker pocket related complications but the use of these devices is limited for single-chamber ventricular pacing as observed in the case of permanent atrial fibrillation, sinus node dysfunction and atrioventricular block. The implant is considered a less invasive approach for patients requiring pacemakers as it does not require surgery like in traditional pacemaker procedures. These devices are implanted through a vein passing close to the outer surface of the upper thighs. Retrieval of this device is also possible without complications as observed in various clinical studies. High implant success rate as per various global clinical trials has also been observed such as 97% & 95.8% implant success rate of St. Jude’s Nanostim in the leadless and leadless II trial respectively.

The estimated market for leadless pacing systems is estimated to be valued at US$ 29.4 Mn in 2017 and is projected to grow at a CAGR of 10.0% during the forecast period. Market for leadless pacing system products is limited with only 2 commercially approved products: Nanostim leadless pacing system by St. Jude’s Medical (now Abbott) and Micra Trans catheter pacing system by Medtronic plc. Product approvals for leadless pacing systems is a major factor impacting market growth. Companies are focusing on acquisitions, product approvals from various regulatory bodies and technical advancements for staying competitive in the global market.

The global Leadless Pacing Systems market is segmented on the basis of expression system, product type, application, end user and region.

Based on application type, the market for leadless pacing systems has been divided into atrial fibrillation, sinus node dysfunction, atrioventricular block and others. Atrial fibrillation segment dominates the leadless pacing systems market by application (as observed in various historical implants performed) with around 55% market share and is expected to remain dominant over the forecast period. This is followed by sinus node dysfunction application segment and atrioventricular block application segment respectively. Based on end users, the market has been segmented into hospitals and ambulatory surgical centers with hospitals dominating the global market because of more procedures performed in hospitals for leadless pacing implants than ambulatory surgical centers as per the trend observed in patient preferences over the globe.

Request A Sample Report@ https://www.persistencemarketresearch.com/samples/12205

Summary of Table of Content

1. Executive Summary

2. Market Introduction

3. Leadless Pacing System Market View Point

4. North America Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025

5. Latin America Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025

6. Europe Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025

7. Asia Pacific (APAC) Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025

8. Middle East and Africa (MEA) Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025

9. Competition Landscape

10. Global Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025, By Region

11. Global Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025, By Application Type

12. Global Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2025, By End User

13. Global Leadless Pacing System Market Analysis 2012–2016 and Forecast 2017–2027

14. Assumptions and Acronyms Used

15. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/leadless-pacing-system-market/toc

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us

Persistence Market Research

305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leadless Pacing Systems Market: Segment Snapshot and Table of Content (2017-2025) here

News-ID: 868224 • Views:

More Releases from Persistence Market Research

Mauritia Flexuosa Fruit Oil Market Set for Steady Growth at 8.5% CAGR Through 2032
Mauritia Flexuosa Fruit Oil Market Set for Steady Growth at 8.5% CAGR Through 20 …
The global Mauritia flexuosa fruit oil market is witnessing steady expansion as demand for plant-based, nutrient-rich oils rises across cosmetics, nutraceuticals, and functional food industries. The market is likely to be valued at US$240.4 million in 2025 and is projected to reach US$425.5 million by 2032, registering a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032. This growth reflects increasing consumer awareness of natural ingredients and the
Hepatocellular Carcinoma (HCC) Treatment Market Size to Grow at 8.8% CAGR Through 2033 - Persistence Market Resaerch
Hepatocellular Carcinoma (HCC) Treatment Market Size to Grow at 8.8% CAGR Throug …
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, primarily stemming from underlying liver diseases such as chronic viral hepatitis (HBV and HCV), alcohol-related liver damage, and metabolic disorders. Over the years, the HCC treatment market has experienced significant growth, driven by advancements in therapeutic strategies, early diagnosis, and improved healthcare access. In this article, we will explore the current trends, growth drivers, challenges, opportunities, and key players
Inhalation CDMO Market to Reach US$14.3 Bn by 2033 at 6.0% CAGR - Persistence Market Resaerch
Inhalation CDMO Market to Reach US$14.3 Bn by 2033 at 6.0% CAGR - Persistence Ma …
The Inhalation Contract Development and Manufacturing Organization (CDMO) market is witnessing substantial growth, driven by the increasing prevalence of respiratory diseases and the rising demand for complex inhalation drug-device combination products. This market, valued at $9.5 billion in 2026, is projected to grow to $14.3 billion by 2033, with a CAGR of 6.0%. The emergence of new technologies, rising outsourcing trends, and growing regulatory expertise have all played pivotal roles
Septoplasty Market to Reach US$5.4Bn by 2033 at 7.3% CAGR - Persistence Market Resaerch
Septoplasty Market to Reach US$5.4Bn by 2033 at 7.3% CAGR - Persistence Market R …
The global septoplasty market is on a significant upward trajectory, driven by a combination of demographic shifts, increasing healthcare awareness, and rapid technological advancements. In 2026, the market is projected to be valued at approximately US$ 3.3 billion and is expected to reach US$ 5.4 billion by 2033, growing at a robust compound annual growth rate (CAGR) of 7.3% during the forecast period from 2026 to 2033. Septoplasty, a surgical

All 5 Releases


More Releases for Leadless

Heart Disease Trends Fueling Growth In The Leadless Pacemaker Market Driver: Lea …
"How Are the key drivers contributing to the expansion of the leadless pacemakers market? The rise in heart disease cases is expected to fuel the growth of the leadless pacemaker market. Heart diseases, which affect the heart's function, are increasing due to aging populations, lifestyle changes, and environmental factors. Leadless pacemakers offer effective treatment for certain heart conditions while minimizing complications from traditional pacemakers. The World Health Organization projected that cancer
Shaping the Leadless Pacemakers Market in 2025: Advancing Cardiac Care The Rise …
How Big Is the Leadless Pacemakers Market Expected to Be, and What Will Its Growth Rate Be?_x000D_ There has been impressive growth in the market size of leadless pacemakers recently. Projected to increase from $0.58 billion in 2024 to $0.68 billion in 2025, it is pegged to grow at a compound annual growth rate (CAGR) of 15.7%. Factors driving this growth during the historic period include the improvement in imaging and
Global Leadless Pacemaker Market Size & Trends
According to a new market research report published by Global Market Estimates, the global leadless pacemaker market is expected to grow at a CAGR of 15.7% from 2023 to 2028. Global leadless pacemaker market growth is driven by increasing geriatric population and the reimbursement policies available. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on "Global Leadless Pacemaker Market - Forecast to 2028'' https://www.globalmarketestimates.com/market-report/leadless-pacemakers-market Key Market
Leadless Cardiac Pacemaker Market - Unleashing Mobility, Embracing Convenience: …
Newark, New Castle, USA - new report, titled Leadless Cardiac Pacemaker Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Leadless Cardiac Pacemaker market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Leadless Cardiac Pacemaker market. The report offers an overview of
Personalized Genomics to Drive the Leadless Pacing System Market
The Leadless Pacing System Market is expected to climb up the ladder of persistence in the next decade. With various healthcare apps on the anvil, there are also mindfulness apps being tabled. They fall in the category of "Wellness apps". With the world wishing for the post-Covid era to function smoothly, these wellness apps are expected to take the healthcare vertical by storm further. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12205
Leadless Pacing Systems Market Report on Recent Adoption 2025
Global Leadless Pacing Systems Market: Snapshot The global market for leadless pacing systems has been growing on account of the advancements in the field of cardiology across the globe. Although leadless pacing systems are a relative new product in the market for cardiovascular treatment devices, they are expected to supersede the demand for all other kinds of cardiovascular devices. Pacemakers that use lead have led to complications during the treatment process,